Thermo Fisher Scientific Inc. announced that manufacturing of Zilretta is underway at its Swindon, U.K. site where a custom “condo” manufacturing suite has been installed to support the launch of Flexion‘s newly approved therapy for osteoarthritis-related knee pain.   The condo was designed specifically for Flexion’s needs – providing the ideal environment for complex formulations and create a manufacturing runway from development to commercialization.   Zilrettais th...